InnoModels Biotechnology is committed to driving technological innovation in the life sciences, and its PDC (Phenotypic Drug Discovery) high-throughput in vitro efficacy technology plays an important role in drug discovery, not only providing highly reduced biological models, but also accelerating the process of drug screening and evaluation, enabling researchers to find promising drug candidates faster and more accurately. PDC technology not only provides highly reductive biological models, but also accelerates the process of drug screening and evaluation, enabling researchers to find potential drug candidates more quickly and accurately.
Definition of PDC High-Throughput In Vitro Efficacy Studies
PDC is a cellular phenotype-based drug discovery method. Compared to traditional target-driven drug discovery, PDC technology focuses on providing more comprehensive information for drug discovery through the comprehensive observation and assessment of drug effects at the cellular level.
InnoModels Bio's PDC high-throughput in vitro drug discovery technology
InnoModels Biotechnology has made remarkable achievements in PDC high-throughput in vitro drug efficacy study technology, and its technology has unique advantages in the following aspects:
1. Multi-parameter determination:
PDC technology allows researchers to simultaneously assess multiple cell phenotypic parameters, such as cell proliferation, cell cycle, apoptosis, etc., providing a more comprehensive understanding of drug effects.
2. Multi-cell type support:
The technology supports the application of multiple cell types, including tumour cells, primary cells, etc., which is suitable for drug research in different disease areas.
3. High-throughput screening:
The PDC technology of InnoModels Biotechnology can screen a large number of drugs in a relatively short time, which improves the research efficiency and provides strong support for efficient drug discovery.
4. Complex disease modelling:
Combined with multi-parameter cellular phenotyping, PDC technology makes it possible to establish more complex disease models, which helps to study the effects of drugs in complex disease environments.

Application Areas
InnoModels Bio's PDC technology has been widely used in the following areas:
Anti-cancer drug development:
Accelerating the discovery and development process of anti-cancer drugs through multi-parameter evaluation of tumour cells.
Neurological disease research:
Helps researchers better understand drug effects in the nervous system by modelling complex neurological diseases.
Infectious Disease Drug Development:
Provides an efficient and comprehensive in vitro research platform for infectious disease research, accelerating the discovery of antiviral drugs.
Conclusion
InnoModels Bio's PDC high-throughput in vitro drug efficacy research technology is not only a model of technological innovation, but also plays an important role in the field of drug discovery and development. Through comprehensive cellular phenotype assessment, this technology provides a more comprehensive and reliable research platform for drug discovery and opens new doors for drug innovation for researchers.